Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
01/2006
01/10/2006CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
01/05/2006WO2006002361A2 2-methylpropanamides and their use as pharmaceuticals
01/05/2006WO2006000355A1 3'-alkoxy spirocyclic tetramic and tetronic acids
01/05/2006WO2005099709A3 Bicyclic heterocycles useful as serine protease inhibitors
01/05/2006WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
01/05/2006US20060004209 Process for preparing highly pure and free-flowing solid of 7-ethyltryptophol
01/05/2006US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance
01/05/2006US20060004083 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
01/05/2006US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto
01/05/2006US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation
01/05/2006US20060004044 3-glyoxylamideindoles for treating cancer
01/05/2006US20060004022 4-, 5-, 6- And 7-indole derivatives useful for the treatment of CNS disorders
01/05/2006US20060004017 Quinazoline derivatives as angiogenesis inhibitors
01/05/2006US20060004009 Ethylenediamine derivatives
01/05/2006US20060003979 Topical compositions of cyclic amides as immunotherapeutic agents
01/05/2006CA2810655A1 Modulators of atp-binding cassette transporters
01/05/2006CA2584502A1 2-methylpropanamides and their use as pharmaceuticals
01/05/2006CA2572141A1 3'-alkoxy spirocyclic tetramic and tetronic acids
01/05/2006CA2572135A1 Sulfonamide compound
01/05/2006CA2571949A1 Modulators of atp-binding cassette transporters
01/05/2006CA2571058A1 Cannabinoid receptor ligands
01/05/2006CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
01/05/2006CA2568802A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists
01/05/2006CA2567851A1 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
01/04/2006EP1611889A1 Antibacterial agent and anticancer agent
01/04/2006EP1611098A1 Compounds having activity at 5ht2c receptor and uses thereof
01/04/2006EP1611097A1 Indole derivatives useful for the treatment of deseases
01/04/2006EP1611096A2 Benzamide modulators of metabotropic glutamate receptors
01/04/2006EP1611090A2 Cannabinoid receptor ligands
01/04/2006EP1611089A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer's disease
01/04/2006EP1611088A2 Hydroxamates as therapeutic agents
01/04/2006EP1610776A2 Ophthalmic compositions for treating ocular hypertension
01/04/2006EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
01/04/2006EP1363873A4 Peptide deformylase inhibitors
01/04/2006EP1319047B1 Cyanine dyes
01/04/2006EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments
01/04/2006CN1717233A 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents
01/04/2006CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same
01/04/2006CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application
01/04/2006CN1234688C 3-arylindole and their use as cb2 receptor agonists
01/04/2006CN1234680C Image forming agent, its precursor and preparing process thereof
01/04/2006CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use
01/03/2006US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative
01/03/2006US6982269 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
12/2005
12/29/2005WO2005123716A1 Indole derivatives as histamine receptor antagonists
12/29/2005WO2005123700A1 Small molecules for treatment of hypercholesterolemia and related diseases
12/29/2005WO2005123677A1 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
12/29/2005WO2005123676A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers
12/29/2005WO2005123675A1 Indoles useful in the treatment of inflammation
12/29/2005WO2005123674A1 Indoles useful in the treatment of inflammation
12/29/2005WO2005123673A1 Indoles useful in the treatment of inflammation
12/29/2005WO2005123672A2 Kinase inhibitors
12/29/2005WO2005123634A1 Fluorene derivative and organic electroluminescent device using same
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005US20050288517 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom
12/29/2005US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
12/29/2005US20050288354 peroxisome proliferator activated receptor scaffold and modulator; 3-[1-(4-butoxy-benzenesulfonyl)-5-metoxy-1H-indol-3-yl]-propionic acid methyl etster; for identification or development of additional active compound; bioassay: binding affinity or specificity; antidiabetic, obesity, metabolic disorder
12/29/2005US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
12/29/2005US20050288351 Azaspiro compounds for the treatment of pain
12/29/2005US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin
12/29/2005US20050288338 Amido compounds and their use as pharmaceuticals
12/29/2005US20050288335 Triamide-substituted heterobicyclic compounds
12/29/2005US20050288329 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor
12/29/2005US20050288318 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
12/29/2005US20050288271 Arylsulfonamides and uses related thereto
12/29/2005US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS
12/29/2005CA2570531A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570365A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570363A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570258A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers
12/29/2005CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases
12/28/2005EP1610341A2 Magnetic random access memory array with coupled soft magnetic adjacent layer
12/28/2005EP1610126A1 A system for determining the electrical potential across a membrane
12/28/2005EP1608650A1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
12/28/2005EP1608625A1 Acutumine and acutumine compounds, synthesis and use
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1497240A4 Non-heating clay composites for building materials
12/28/2005EP1432415B1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
12/28/2005EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function
12/28/2005EP1161418B1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1714076A Novel aryl ureido benzoic acid derivatives and their use
12/28/2005CN1714060A Method for deuteration or tritiation of heterocyclic ring
12/28/2005CN1713908A Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
12/28/2005CN1233630C N-substituted indole derivative preparation method
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979586 Magnetic random access memory array with coupled soft adjacent magnetic layer
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2237910C Excitatory amino acid derivatives
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/27/2005CA2156287C Indolin-2-one derivative
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121093A1 Lxr receptor modulators
12/22/2005WO2005121085A1 Aza-bicyclo`3.1.0!hex-1-yl derivatives active as nk1 antagonists
12/22/2005WO2005121084A1 A method of preparation of ramipril
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions